Article

What We're Reading: Pfizer Kickback Case; Concerns for Association Health Plans; Swallowable Sensor

Author(s):

As part of a settlement with the Department of Justice, Pfizer will pay the government nearly $24 million to resolve kickback allegations; both blue and red states worry association health plans could become targets for scam artists; a prototype of a swallowable sensor that can send results to a smartphone app will provide a peek into the digestive system.

Pfizer to Pay $24 Million in Kickback Settlement

States Worry About Association Health Plans

Swallowable Sensor Can Provide Insight Into the Gut

As part of a settlement with the Department of Justice, Pfizer will pay the government nearly $24 million to resolve kickback allegations. According to Kaiser Health News, the lawsuit claimed that Pfizer donated to the Patient Access Network Foundation and steered Medicare patients to the foundation to cover copays for Pfizer’s drugs. Federal law does not allow drug makers to directly offer copay assistance to patients on Medicare or Medicaid.Association health plans that the Trump administration is promoting as a cheaper alternative to Affordable Care Act health plans could become targets for scam artists. Both blue and red states are worried that their authority over plans will be weakened and plans will be sold that have skimpy or nonexistent benefits, reported Stateline. Insurance regulators in California, Iowa, Minnesota, New Mexico, and Washington have raised concerns and want states to be able to establish protections and financial stability standards, as well as being able to bar plans from doing business in their states.A prototype of a swallowable sensor that can send results to a smartphone app will provide a peek into the digestive system. STAT reported that the sensor could help understand why the digestive system isn’t working properly or a new way to diagnose diseases. The new tool uses engineered bacteria and a tiny electrical circuit to detect other molecules in the digestive tract.

Related Videos
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Galen Shearn-Nance, BS, and Johnie Rose, MD, PhD
Galen Shearn-Nance, BS
Dr Johnie Rose
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Tiffany Meng, PharmD, oncology pharmacist, UCSF Health
Dr Andrew S. Oseran
o Richard Hughes IV, JD, MPH, Epstein Becker Green
Dr Andrew S. Oseran
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo